Partial break in tolerance of NKG2A−/LIR-1− single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Partial break in tolerance of NKG2A−/LIR-1− single KIR+ NK cells early in the course of HLA-matched, KIR-mismatched hematopoietic cell transplantation

Published:2017-05-08 Issue:8 Volume:52 Page:1144-1155
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Rathmann S,Keck C,Kreutz C,Weit N,Müller M,Timmer J,Glatzel S,Follo M,Malkovsky M,Werner M,Handgretinger R,Finke J,Fisch P

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt201781.pdf

Reference53 articles.

1. Ruggeri L, Capanni M, Casucci M, Volpi I, Tosti A, Perruccio K et al. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999; 94: 333–339.

2. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295: 2097–2100.

3. Giebel S, Locatelli F, Lamparelli T, Velardi A, Davies S, Frumento G et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 2003; 102: 814–819.

4. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L . What is a natural killer cell? Nat Immunol 2002; 3: 6–8.

5. Lanier LL . NK cell recognition. Annu Rev Immunol 2005; 23: 225–274.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity;Clinical & Translational Immunology;2021-01

2. Non‐KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells;International Journal of Immunogenetics;2020-12-22

3. In memoriam: Paul Fisch (1959–2018) our dear friend, pioneer of γδ T cell research, esteemed scientist, and dedicated clinician;Clinical & Translational Immunology;2019-01